Targeted therapies meet AI-driven discovery as these biotech innovators reveal sharply contrasting financials, risk factors, ...

The first true Infiniti rival to the likes of Mercedes-AMG and BMW M—just to name a few—will have to wait a little longer.

Read Genethon's Newsletter for advances in novel AAV vectors and clinical progress in Duchenne muscular dystrophy, limb-girdle muscular dystrophy and Crigler-Najjar syndromeGenethon, a unique non-prof ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high cholesterol to a rare muscular disorder ...

Basel, July 2, 2026 – Novartis today announced that the European Commission (EC) has approved Itvisma ® (onasemnogene ...

Further tests would be needed but it could supplement the existing treatment ...

By some benchmarks, Julia code can run 10X to 1,000X faster than Python—but there’s a reason it’s not a very popular ...

For nearly 25 years, Nina Foundation has worked with thousands of people living with spinal cord injuries (SCI), helping them ...

The engineers of the Ferrari HyperSail project detail how they intead to power the massive foiler. The post Powering the HyperSail appeared first on Sailing World.

The crushing expectations in elite college admissions for long term and in-depth talent and specialization, a "hook", is ...

You've been in the gym long enough to know your way around a barbell. You've put in the reps, eaten the protein, and done everything right. So why does progress seem to slow to a crawl the longer you ...

The Red Storm’s center of the future could make an immediate impact while he learns behind Ruben Prey in his freshman year.